Product Information
XCOPRI 12.5-25 MG TITRATION PK is a brand product labeled by SK Life Science, Inc., priced at $3.9069 per EA under NDC 71699020128. Its NADAC has been published 267 times since May 19, 2021.
Manufacturer
SK Life Science, Inc.NDC
71699020128
Classification
Brand
Dosage Form
KIT
Route
ORAL
Last Updated
6/17/2026
Approval Type
New Drug (NDA)
FDA Application
NDA212839On Market Since
3/12/2020
Price Statistics
The NADAC for XCOPRI 12.5-25 MG TITRATION PK has been published 267 times since May 19, 2021, and over the history we have for it it has risen 21.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.9069 per EA |
|---|---|
| All-time high | $3.9093 (Jun 10, 2026) |
| All-time low | $3.2152 (May 19, 2021) |
| 52-week high | $3.9093 |
| 52-week low | $3.7820 |
| Median price | $3.4940 |
| Average price | $3.5591 |
| Largest weekly change | +6.0% (Jan 3, 2024) |
| Weeks tracked | 267 |
| Tracking since | May 19, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of XCOPRI 12.5-25 MG TITRATION PK?
The current National Average Drug Acquisition Cost (NADAC) for XCOPRI 12.5-25 MG TITRATION PK, manufactured by SK Life Science, Inc., is $3.9069 per EA (NDC 71699020128), effective Jun 24, 2026.
How has the price of XCOPRI 12.5-25 MG TITRATION PK changed over time?
Over the history we have for it, the NADAC for XCOPRI 12.5-25 MG TITRATION PK has risen 21.5%. It has been tracked across 267 weekly CMS publications since May 19, 2021.
What are the highest and lowest recorded NADAC prices for XCOPRI 12.5-25 MG TITRATION PK?
Since May 19, 2021, the NADAC for XCOPRI 12.5-25 MG TITRATION PK has ranged from a low of $3.2152 (May 19, 2021) to a high of $3.9093 (Jun 10, 2026), with a median of $3.4940 per EA.
Are there cheaper alternatives to XCOPRI 12.5-25 MG TITRATION PK?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as XCOPRI 12.5-25 MG TITRATION PK, but none are currently priced below it.
Who manufactures XCOPRI 12.5-25 MG TITRATION PK?
XCOPRI 12.5-25 MG TITRATION PK (NDC 71699020128) is labeled by SK Life Science, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification